Fig. 5From: Predicting response to neo-adjuvant chemotherapy and assessment of residual disease in breast cancer using contrast-enhanced spectral mammography: a combined qualitative and quantitative approacha Pre-NAC mammogram; spiculated LIQ mass. b Post-NAC mammogram; no change in size. c Pre-NAC CESM; lesions. d Post-NAC CESM; decreased enhancement without size change. Both RECIST 1.1 and combined response evaluation; non-responder. Pathology; Miller-Payne grade 1Back to article page